• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

RSNA: Siemens Healthineers Adopts NVIDIA’s MONAI Deploy for Faster AI Deployment

by Fred Pennic 12/02/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Siemens Healthineers, a global leader in medical technology, has adopted NVIDIA MONAI Deploy to accelerate integrating AI workflows into its Syngo Carbon and syngo.via enterprise imaging platforms. 

– NVIDIA’s MONAI platform is revolutionizing the field of medical imaging by accelerating the development and deployment of AI applications. This open-source framework is empowering healthcare professionals and researchers to harness the power of AI to improve diagnostic accuracy, enhance workflows, and ultimately deliver better patient care.

The Challenge of Medical Image Processing

With billions of medical imaging tests performed annually worldwide, efficiently processing and evaluating these images is crucial for timely diagnosis and treatment. AI has emerged as a powerful tool to address this challenge, but deploying AI applications in clinical settings has been hindered by the complexity and variability of development frameworks.

MONAI Deploy: Bridging the Gap from Research to Clinical Practice

NVIDIA’s MONAI Deploy module is designed to streamline integrating AI workflows into clinical practice. It allows developers to build and deploy medical AI applications with ease, enabling faster translation of research innovations into real-world clinical settings.

Benefits of MONAI Deploy

  • Simplified AI Deployment: Streamlines the process of developing and integrating AI applications into clinical workflows.
  • Accelerated Innovation: Reduces the time required to bring AI innovations from research to clinical practice.
  • Enhanced Efficiency: Improves the speed and efficiency of AI integration, enabling faster and more accurate diagnoses.
  • Increased Accessibility: Makes AI-powered tools more accessible to healthcare professionals and researchers.

The collaboration has significantly reduced the time required to deploy AI models from months to just a few clicks, empowering healthcare institutions to leverage the latest advancements in AI-powered medical imaging.

“By accelerating AI model deployment, we empower healthcare institutions to harness and benefit from the latest advancements in AI-based medical imaging faster than ever,” said Axel Heitland, head of digital technologies and research at Siemens Healthineers. “With MONAI Deploy, researchers can quickly tailor AI models and transition innovations from thelab to clinical practice, providing thousands of clinical researchers worldwide access to AI-driven advancements directly on their syngo.via and Syngo Carbon imaging platforms.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |